Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
sector : Health technology tags : Therapy save search
REGENXBIO to Participate in Chardan's 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
Published: 2024-04-24 (Crawled : 11:00) - prnewswire.com
RGNX | $15.71 -1.2% 49K
|
Health Technology
|
| O: 0.03%
H: 0.0%
C: 0.0%
genetic cell therapy
Novartis radioligand therapy Lutathera® FDA approved as first medicine specifically for pediatric patients with gastroenteropancreatic neuroendocrine tumors
Published: 2024-04-23 (Crawled : 18:00) - globenewswire.com
NVSEF | News | $96.0 52K
|
Health Technology
|
| O: 1.69%
H: 0.02%
C: -0.74%
NVS | News | $97.515 0.24% 820K
|
Health Technology
|
| O: 4.32%
H: 0.0%
C: 0.0%
lutathera fda first approved tumors for novartis therapy
Artelo Biosciences Announces Publication of Peer-Reviewed Article Highlighting FABP7 as a Promising Novel Target in Cancer Therapy
Published: 2024-04-23 (Crawled : 12:30) - globenewswire.com
ARTL | News | $1.31 1.5K
|
Health Technology
|
| O: 0.77%
H: 2.29%
C: 0.0%
cancer publication therapy
Adicet Bio Highlights Preclinical Data Supporting IND Readiness for ADI-270 in an Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting
Published: 2024-04-22 (Crawled : 23:00) - biospace.com/
ACET | News | $1.925 -8.33% 640K
|
Health Technology
|
| O: 2.56%
H: 2.0%
C: 0.0%
adi-270 presentation cell preclinical for meeting therapy
Regeneron to Highlight Advances in Genetic Medicine Research at American Society of Gene and Cell Therapy (ASGCT)
Published: 2024-04-22 (Crawled : 22:00) - globenewswire.com
SNY | News | $46.82 -1.82% 510K
|
Health Technology
|
| O: 1.7%
H: 0.0%
C: 0.0%
REGN | News | $911.73 0.49% 97K
|
Health Technology
|
| O: 0.51%
H: 0.78%
C: 0.18%
genetic cell research therapy
Generation Bio Announces the Acceptance of Five Abstracts and an Invited Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting
Published: 2024-04-22 (Crawled : 21:00) - globenewswire.com
GBIO | News | $3.07 -5.83% 24K
|
Health Technology
|
| O: 1.78%
H: 18.88%
C: 13.99%
presentation cell meeting therapy
CRISPR Therapeutics to Present Oral Presentation at the American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting
Published: 2024-04-22 (Crawled : 21:00) - globenewswire.com
CRSP | News M | $56.61 0.36% 270K
|
Health Technology
|
| O: 0.49%
H: 4.9%
C: 0.86%
crispr presentation cell meeting therapeutics therapy
Voyager Therapeutics to Present Broad Set of Translational Data Supporting IV-Delivered, CNS Gene Therapy Programs Advancing Toward Clinical Trials at the ASGCT 27th Annual Meeting
Published: 2024-04-22 (Crawled : 20:00) - globenewswire.com
VYGR | News | $7.555 -1.24% 55K
|
Health Technology
|
| O: 0.4%
H: 2.37%
C: 0.66%
SGMO | News | $0.497 -4.59% 400K
|
Health Technology
|
| O: 1.96%
H: 9.62%
C: 0.0%
NBIX | News M | $139.34 -0.53% 230K
|
Health Technology
|
| O: 5.49%
H: 2.84%
C: -0.65%
trials meeting set therapeutics therapy
Editas Medicine to Present Pre-clinical Data Demonstrating Progression of in vivo Medicines Pipeline at the American Society of Gene and Cell Therapy Annual Meeting
Published: 2024-04-22 (Crawled : 20:00) - globenewswire.com
EDIT | News | $5.415 -0.82% 340K
|
Health Technology
|
| O: 1.07%
H: 4.59%
C: -3.53%
pre-clinical pipeline cell meeting therapy
Kura Oncology Receives Breakthrough Therapy Designation for Ziftomenib in NPM1-Mutant AML
Published: 2024-04-22 (Crawled : 12:00) - globenewswire.com
KURA | News | $18.675 -0.29% 94K
|
Health Technology
|
| O: 4.56%
H: 4.64%
C: -0.76%
designation for aml therapy
Passage Bio to Present at Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
Published: 2024-04-22 (Crawled : 11:00) - globenewswire.com
PASG | News | $1.23 4.5K
|
Health Technology
|
| O: 0.0%
H: 3.48%
C: -0.87%
genetic cell therapy
Ocugen Announces Dosing Completion of Subjects with Geographic Atrophy in Cohort 2 of Phase 1/2 ArMaDa Clinical Trial of OCU410—A Modifier Gene Therapy
Published: 2024-04-19 (Crawled : 11:00) - globenewswire.com
OCGN | News A | $1.205 -3.6% 2.5M
|
Health Technology
|
| O: -15.41%
H: 0.0%
C: 0.0%
ocu410 armada trial therapy
U.S. FDA Approves Subcutaneous Administration of Takeda’s ENTYVIO® (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Crohn’s Disease
Published: 2024-04-18 (Crawled : 23:00) - biospace.com/
TAK | News | $13.23 -1.12% 300K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
entyvio fda disease active for therapy
Poseida Therapeutics Announces Strong Lineup of Presentations at the American Society of Gene and Cell Therapy 27th Annual Meeting
Published: 2024-04-18 (Crawled : 19:00) - biospace.com/
PSTX | $2.085 -3.47% 80K
|
Health Technology
|
| O: 0.25%
H: 0.0%
C: 0.0%
cell meeting therapeutics therapy
Poseida Therapeutics Hosts Gene Therapy R&D Day Highlighting New Scientific Advancements and Pipeline Focus
Published: 2024-04-17 (Crawled : 15:00) - biospace.com/
PSTX | $2.085 -3.47% 80K
|
Health Technology
|
| O: 0.0%
H: 2.46%
C: 0.49%
day pipeline therapeutics therapy
Artiva Biotherapeutics Announces First Patient Dosed in Phase 1 Trial of AlloNK® Cell Therapy Candidate in Lupus Nephritis
Published: 2024-04-17 (Crawled : 15:00) - biospace.com/
AFMD | $5.35 8.9K
|
Health Technology
|
| O: -2.42%
H: 0.0%
C: 0.0%
allonk first candidate lupus cell trial therapy
Intra-Cellular Therapies Announces Positive Phase 3 Topline Results from Study 501 Evaluating Lumateperone as Adjunctive Therapy in Patients with Major Depressive Disorder
Published: 2024-04-16 (Crawled : 11:00) - globenewswire.com
ITCI 4 d | $73.82 -0.26% 120K
|
Health Technology
|
| O: 14.75%
H: 12.75%
C: 6.04%
positive topline therapy results study
CAR T-Cell Therapy for Non-Hodgkin's Lymphoma Market to Showcase Significant Growth at a CAGR of 15% by 2032 | DelveInsight
Published: 2024-04-15 (Crawled : 22:00) - prnewswire.com
INCY | $51.27 -0.74% 170K
|
Health Technology
|
| O: -0.17%
H: 1.41%
C: -0.22%
t-cell for therapy growth market
Caribou Biosciences Announces Oral Presentation on In Vivo Cas12a chRDNA Genome Editing at the 27th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT)
Published: 2024-04-15 (Crawled : 13:00) - globenewswire.com
CRBU | $3.865 -2.89% 230K
|
Health Technology
|
| O: -0.71%
H: 5.27%
C: -2.4%
presentation cell meeting therapy
Phio Pharmaceuticals Announces Upcoming Presentation at the 27th Annual Meeting of the American Society of Cell and Gene Therapy (ASCGT)
Published: 2024-04-11 (Crawled : 12:00) - phiopharma.com
PHIO | News | $0.686 -2.0% 30K
|
Health Technology
|
| O: 3.8%
H: 1.15%
C: -1.19%
presentation cell pharmaceuticals meeting therapy
Gainers vs Losers
| 57% | 43% |
Top 10 Gainers
CSSE 4 | $0.3686 142.02% 76M
|
Consumer Services
CZOO | $11.685 134.17% 7.6M
|
BOF | $2.05 75.21% 78M
|
AMST | $3.14 57.0% 59M
|
Technology Services
LICN | $0.7885 40.8% 11M
|
TROO | $1.51 38.53% 5.6M
|
Manufacturing
MULN | News | $3.7 35.53% 6.4M
|
Information
WHLM | $6.61 30.12% 400K
|
Commercial Services
RILY | $27.91 28.5% 8.9M
|
Finance
RBBN 4 | $3.25 26.46% 1.5M
|
Electronic Technology
Your saved searches
Save your searches and get alerts when important news are released.